Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Sep;31(9):1287-1291.
doi: 10.1136/ijgc-2021-002586.

Determining post-operative morbidity and mortality following gynecological oncology surgery: protocol for a multicenter, international, prospective cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative-GO SOAR)

Collaborators, Affiliations
Free article
Multicenter Study

Determining post-operative morbidity and mortality following gynecological oncology surgery: protocol for a multicenter, international, prospective cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative-GO SOAR)

Faiza Gaba et al. Int J Gynecol Cancer. 2021 Sep.
Free article

Abstract

Background: The Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR) aims to develop a network of gynecological oncology surgeons, surgical departments, and other interested parties that will have the long-term ability to collaborate on outcome studies. The protocol for the first collaborative study is presented here.

Primary objective: To evaluate international variation in 30-day post-operative morbidity and mortality following gynecological oncology surgery between very high/high and medium/low human development index country settings.

Hypothesis: There is no variation in post-operative morbidity and mortality following gynecological oncology surgery between very high/high and medium/low human development index country settings.

Study design: International, multicenter, prospective cohort study. Patient data will be collected over a consecutive 30-day period through gynecological oncology multidisciplinary teams/tumor boards and clinics across different human development index country groups. All data are collected on a customized, secure, password protected, central REDCap database.

Major inclusion/exclusion criteria: Inclusion criteria include women aged ≥18 years undergoing elective/emergency, curative/palliative surgery for primary/recurrent tubo-ovarian/peritoneal, endometrial, cervical, vulval, vaginal, gestational trophoblastic malignancies. Surgical modality may be open, minimal access (laparoscopic/robotic), or vaginal.

Primary endpoint: 30-day post-operative morbidity and mortality defined as per Clavien-Dindo classification system.

Sample size: 1100 (550/arm).

Estimated dates for completing accrual and presenting results: It is estimated recruitment will be completed by 2022 and results published by 2023.

Trial registration: ClinicalTrials.gov registry: NCT04579861 (https://clinicaltrials.gov/ct2/show/NCT04579861).

Keywords: gynecologic surgical procedures; postoperative complications; surgical oncology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: FG declares funding from The NHS Grampian Endowment Fund, Medtronic, Karl Storz for the GO SOAR1 study and is Chief Investigator.

Publication types

Associated data

LinkOut - more resources